ZNF180 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.563670E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.999200E-01
Normal-vs-Stage2
9.297200E-03
Normal-vs-Stage3
1.287210E-01
Normal-vs-Stage4
2.453600E-01
Stage1-vs-Stage2
4.816100E-02
Stage1-vs-Stage3
4.317700E-02
Stage1-vs-Stage4
5.535200E-01
Stage2-vs-Stage3
1.592000E-01
Stage2-vs-Stage4
4.740200E-01
Stage3-vs-Stage4
5.944000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.709630E-02
Normal-vs-AfricanAmerican
1.578430E-01
Normal-vs-Asian
3.661600E-02
Caucasian-vs-AfricanAmerican
6.416000E-01
Caucasian-vs-Asian
6.879600E-01
AfricanAmerican-vs-Asian
4.950000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.959760E-02
Normal-vs-Female
1.716010E-02
Male-vs-Female
3.637200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.549200E-01
Normal-vs-Age(41-60Yrs)
3.740200E-02
Normal-vs-Age(61-80Yrs)
1.454120E-02
Normal-vs-Age(81-100Yrs)
1.097780E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.097400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.327800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.342390E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.699820E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.791820E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.576000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.146120E-02
Normal-vs-Daily Drinker
1.325830E-02
Normal-vs-Weekly Drinker
4.120200E-03
Normal-vs-Occasional Drinker
1.269020E-01
Normal-vs-Social Drinker
3.750500E-02
Non Drinker-vs-Daily Drinker
6.673000E-01
Non Drinker-vs-Weekly Drinker
6.493600E-01
Non Drinker-vs-Occasional Drinker
4.217600E-02
Non Drinker-vs-Social Drinker
4.730200E-01
Daily Drinker-vs-Weekly Drinker
3.767800E-01
Daily Drinker-vs-Occasional Drinker
9.636000E-02
Daily Drinker-vs-Social Drinker
7.229800E-01
Weekly Drinker-vs-Occasional Drinker
2.256300E-02
Weekly Drinker-vs-Social Drinker
2.560600E-01
Occasional Drinker-vs-Social Drinker
2.481800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.542100E-02
Normal-vs-Grade 2
2.968100E-02
Normal-vs-Grade 3
5.958200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.448180E-01
Grade 1-vs-Grade 3
2.755200E-01
Grade 1-vs-Grade 4
6.542100E-02
Grade 2-vs-Grade 3
6.518400E-01
Grade 2-vs-Grade 4
2.968100E-02
Grade 3-vs-Grade 4
5.958200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.060620E-03
Normal-vs-NonDiabetic
1.562210E-02
Diabetic-vs-NonDiabetic
5.520100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.270100E-02
Normal-vs-NoPancreatitis
7.664000E-03
Pancreatitis-vs-NoPancreatitis
3.438800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.609700E-02
Normal-vs-N1
7.498300E-03
N0-vs-N1
3.430000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.626400E-01
Normal-vs-TP53-NonMutant
2.049800E-01
TP53-Mutant-vs-TP53-NonMutant
1.373380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
